Efficacy of the Anti‐CandidarAls3p‐N or rAls1p‐N Vaccines against Disseminated and Mucosal Candidiasis
Open Access
- 15 July 2006
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 194 (2) , 256-260
- https://doi.org/10.1086/504691
Abstract
We have shown that vaccination with the recombinant N terminus of Als1p (rAls1p-N) protects mice against disseminated and oropharyngeal candidiasis.Keywords
This publication has 0 references indexed in Scilit: